OSCR
Oscar Health, Inc.
OSCR has the edge over WGS overall, supported by stronger fundamentals and lower modeled downside.
WGS
GeneDx Holdings Corp.
WGS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
WGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Strong |
WGS's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
WGS PE Valuation
WGS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
WGS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect WGS to return to profit, with revenue growing.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over WGS on earnings quality, reporting a profit while its opponent remains loss making.
WGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | — |
| Q3 2026 | -$3.76 | -3518% |
| Q2 2026 | -$3.62 | -5271% |
| Q1 2026 | -$2.66 | -$1.27 |
| Q4 2025 | -$0.73 | +$1.21 |
| Q3 2025 | $0.11 | +$3.01 |
| Q2 2025 | $0.07 | +$4.30 |
| Q1 2025 | -$1.39 | +$3.58 |
| Q4 2024 | -$1.94 | +$5.29 |
WGS has swung to a loss: it lost $3.76 per share over the past year, after a profit the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over WGS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over WGS on profitability, with a higher operating margin.
WGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $123.1M | +5.4% |
| Q2 2026 | $114.4M | +11% |
| Q1 2026 | $102.3M | +17% |
| Q4 2025 | $121M | +27% |
| Q3 2025 | $116.7M | +52% |
| Q2 2025 | $102.7M | +46% |
| Q1 2025 | $87.1M | +40% |
| Q4 2024 | $95.6M | +67% |
WGS's revenue has grown year over year for 11 quarters in a row: $123M last quarter, up 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.5% | -5.7 points |
| Q2 2026 | -15% | -24 points |
| Q1 2026 | -56% | -51 points |
| Q4 2025 | -12% | -21 points |
| Q3 2025 | -2.8% | +7.3 points |
| Q2 2025 | 8.7% | +24 points |
| Q1 2025 | -5.2% | +17 points |
| Q4 2024 | 9.2% | +54 points |
WGS's operating margin was −8.5% last quarter, down 5.7 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over WGS on cash generation, producing positive trailing cash flow while its opponent burns cash.
WGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.8M | -265% |
| Q2 2026 | -$39.1M | -586% |
| Q1 2026 | -$38.9M | -1059% |
| Q4 2025 | -$7.4M | -$1.2M |
| Q3 2025 | $9.6M | +$14.6M |
| Q2 2025 | $8.1M | +$13.9M |
| Q1 2025 | $4.1M | +$20.9M |
| Q4 2024 | -$6.2M | +$26M |
WGS has burned cash in almost every quarter: −$101M over the past year, against $15M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
WGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +170K shares |
| 1 year | +3.8% | +1.1M shares |
| 3 years | +16% | +4.1M shares |
WGS has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
WGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
WGS has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
WGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 14.6 | Oversold |
WGS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
WGS PE vs Healthcare Sector
| Metric | WGS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
WGS has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over WGS on trend strength, trading above more of its moving averages.
WGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.5 | 22% below |
| 20 week MA | $72.7 | 29% below |
| 50 week MA | $79.8 | 35% below |
| 100 week MA | $89.1 | 42% below |
| 200 week MA | $54.0 | 4% below |
WGS is in a downtrend: it's below all five of its weekly moving averages, and 4% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over WGS on returns for 2026, with the stronger performance.
WGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $323.4 | $382.5 | +18% |
| 2021 | $382.5 | $154.1 | -60% |
| 2022 | $154.1 | $8.02 | -95% |
| 2023 | $8.02 | $2.75 | -66% |
| 2024 | $2.75 | $78.1 | +2738% |
| 2025 | $78.1 | $133.8 | +71% |
| 2026 YTD | $133.8 | $51.9 | -61% |
WGS's yearly returns have swung widely, from +2738% in 2024 to −95% in 2022. It's down 61% so far in 2026.